The global robotic surgery market size was valued at USD 10.10 Billion in 2023 and it is projected to reach USD 37.36 Billion by 2032, growing at a CAGR of 16.5% during the forecast period (2024–2032).
The global market for robotic surgery is anticipated to expand over the projection period due to increasing surgical processes being performed worldwide, owing to the surging cases of chronic illnesses. Moreover, there has been a rising demand for minimally invasive surgeries in recent years, as minimally invasive surgery offers several advantages, like lower postoperative complications, shorter hospital stays, faster recovery, and better cosmetic outcomes, thereby boosting robotic surgery market growth.
Robotic or robot-assisted surgery is a minimally invasive surgery that uses robotic equipment to carry out surgical procedures. These systems are operated by surgeons who control the robotic arms and equipment from a console. The robotic system translates the surgeon's hand gestures into accurate movements of the surgical instruments.
Robotic surgery provides numerous advantages for patients and surgeons, including less blood loss, pain, scarring, risk of infection, and recovery time. It also enhances visualization, skill, and the ability to reach difficult locations. Robotic surgery is extensively employed in various medical fields, including general, gynecological, orthopedic, neurology, urology, and cardiovascular surgery. It continues to expand with technological advancements, presenting new options for intricate and delicate procedures.
The increasing global incidence of chronic diseases is driving the need for efficient and sophisticated surgical treatment options. As a result of this factor, there is a growing number of surgical procedures being conducted. It is further predicted to expand, promoting the development of robotic-assisted procedures in healthcare as they are more efficient and bring significant benefits to patients and surgeons.
The research paper published in September 2020 titled "Estimation of the National Surgical Needs in India by Enumerating the Surgical Procedures in an Urban Community Under Universal Health Coverage" estimated that roughly 11% of the world's illness burden required surgical or anesthetic care. As opposed to the global estimate of 5,000 procedures per 100,000 people, the Indian population's surgical demands are predicted to require 3,646 surgeries annually. Thus, it is anticipated that the market will experience growth over the projected timeframe due to the increasing global demand for surgical operations.
Minimally invasive surgery is a surgical procedure characterized by smaller incisions, fewer cuts, and less tissue damage than open surgery. MIS are becoming increasingly popular due to their lower risk and trauma compared to other procedures. MIS has gained appeal among patients and surgeons because of its advantages, such as decreased postoperative problems, shorter hospital stays, faster recovery, and better cosmetic outcomes.
Robotic surgery is a minimally invasive surgery (MIS) that enhances these advantages by offering enhanced precision, consistency, command, and effectiveness. According to a report by Straits Research, the global MIS market is predicted to grow at a CAGR of 7.8% between 2020-2030. Due to the increasing need for minimally invasive surgery (MIS), the market for robotic surgery is expected to expand rapidly as robotic systems are increasingly used in surgical procedures.
One of the primary issues facing the robotic surgery industry is the high cost of obtaining, maintaining, and operating robotic systems and performing robotic treatments. As per a study conducted by the American Congress of Obstetricians and Gynecologists, the mean expense for a robotic hysterectomy was USD 8,868, in contrast to USD 6,651 for a laparoscopic hysterectomy, resulting in a 1.5 to 3-fold increase.
According to a study published in the Journal of Urology, the mean expense for a robotic prostatectomy was USD 10,621, whereas a laparoscopic prostatectomy costs USD 8,978 on average, and an open prostatectomy costs USD 7,204 on average. Moreover, the high expense of robotic surgery is mainly related to the pricey robotic equipment, instruments, accessories, and training necessary for their utilization. The high cost of robotic surgery may limit its affordability and accessibility, especially in developing and low-income nations, and hamper the market expansion.
The market growth is propelled by the ongoing innovation and advancement of novel robotic systems that provide superior features, functionality, and performance. For instance, in January 2024, the da Vinci XI, which was hailed as the most advanced robotic surgical system in the world, was introduced by St. Luke's Medical Center. As per the SLMC, the advanced platform enables surgeons to carry out intricate surgeries with heightened accuracy and command, resulting in increased patient results. The technology allows for 3D high-definition vision, providing surgeons with a crystal-clear picture of the surgery site.
Similarly, in February 2021, CritiCare Asia Group of Hospitals announced the addition of a second, advanced robot to perform Robotic Assisted Total Knee Replacement Surgery at its newly opened center in Malad (West), Mumbai. This advanced technology system utilizes state-of-the-art AI, computer-assisted technologies, and robots to assist surgeons in complicated procedures. These technological advances are projected to enhance the acceptance and need for surgical robots in the healthcare sector, thereby creating opportunities for market growth.
| Study Period | 2020-2032 | CAGR | 16.5% |
| Historical Period | 2020-2022 | Forecast Period | 2024-2032 |
| Base Year | 2023 | Base Year Market Size | USD 10.10 Billion |
| Forecast Year | 2032 | Forecast Year Market Size | USD 37.36 Billion |
| Largest Market | North America | Fastest Growing Market | Asia-Pacific |
Based on region, the global robotic surgery market share is bifurcated into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa.
North America is the most significant global market shareholder and is expected to expand substantially during the forecast period. The overall expansion of the North American market for robotic surgery is propelled by the escalation in public and private healthcare spending and the increasing adoption of minimally invasive surgeries. In March 2022, the federal government introduced Bill C-17 in the House of Commons, which offered USD 2 billion in additional healthcare funds to clear 700,000 surgeries and other medical operations postponed by the COVID-19 pandemic and support hundreds of thousands of more surgeries. These surgery increases will boost robotic surgery in the region.
Moreover, this region has a higher need for surgical procedures because of the high prevalence of chronic diseases and the growing geriatric population. The WHO's October 2021 Fact Sheet on Aging and Health states that the global population of individuals aged 60 and over reached 1 billion in 2020. The population is projected to rise to 1.4 billion by 2030. This demographic exhibits a higher susceptibility to contracting diseases and undergoing surgical procedures. Consequently, the region will experience a surge in the acceptance of robotic surgery, which is anticipated to propel the market's expansion.
Furthermore, market players have witnessed an increase in introducing sophisticated surgical robots. For instance, in September 2023, US Medical Innovations (USMI) and the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) announced the debut of the new Canady Robotic AI Surgical System. It is the world's first artificial intelligence (AI) robotic system that generates cold atmospheric plasma (CAP) and a three-dimensional non-contact bioelectric pulsed electromagnetic field. Such developments are likely to enhance the market expansion.
Asia-Pacific is expected to develop at the highest CAGR, owing to the large and growing population, the increasing healthcare expenditure, the rising prevalence of chronic diseases, and the improving healthcare infrastructure. Moreover, the regional market expansion is anticipated to be propelled by various awareness and training programs organized by governmental and non-governmental organizations. In May 2023, AIIMS New Delhi and India Medtronic jointly announced the establishment of a cutting-edge surgical robotics training center at AIIMS, New Delhi. The training center will offer a comprehensive spectrum of training to expand the knowledge and skill set in RAS, ranging from basic skills training to procedural training to more advanced and specialist areas in soft-tissue surgery.
Furthermore, participants in the robotic surgery sector are making progress in developing robotic surgical systems. In April 2022, Intuitive announced the debut of My Intuitive App (MIA) in its Indian division. MIA is a distinctive platform designed for doctors in India who utilize da Vinci surgical systems. The My Intuitive App provides a single point of access for surgeons, making surgery data discoverable and actionable. It records the ergonomic preferences of surgeons, the timeframes for cases, and the instruments utilized. Collectively, these factors lead to the expansion of the market.
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
The global market is segmented by application and end-user industry.
The global market is bifurcated into orthopedics, neurology, urology, gynecology, general surgery, and other applications.
Orthopedic surgery, or orthopedics, is a medical specialty that deals with identifying, managing, preventing, and recovering conditions and traumas affecting the musculoskeletal system. Orthopedic surgeons commonly treat problems such as fractures, arthritis, ligament injuries, tendon injuries, congenital disorders, spine abnormalities, and sports-related injuries. The spike in orthopedic procedures is the primary catalyst for implementing surgical robots in orthopedics. According to the Wolters Kluwer Journal, the robotic surgery market growth is enhanced using surgical robots in around 700,000 knee surgeries conducted annually in the United States.
Moreover, the market's primary players continually develop innovative goods to meet the increasing demand. For instance, in January 2019, Zimmer Biomet got FDA permission for the ROSA ONE Spine, a surgical navigation system that enables surgeons to execute minimally invasive and complex spine treatments. The ROSA knee platform incorporates advanced 3D pre-operative planning tools, providing real-time tissue and bone structure information throughout surgical procedures.
The global market for robotic surgery is segmented into hospitals, ambulatory surgical centers, and other end-users.
The hospitals segment owns the highest market share. The hospitals segment accounted for the highest part of the market, owing to the high volume and variety of surgical procedures performed in hospitals, the availability of advanced infrastructure and equipment, and the presence of professional and trained surgeons. Moreover, the healthcare sector will experience the highest CAGR due to the growing investments in the healthcare industry, the increasing utilization of surgical robots for various surgical procedures, the rise in the prevalence of chronic diseases and traumatic incidents, and the presence of reimbursement policies for surgical interventions.
